National Comprehensive Cancer Network



About NCCN

Prostate Cancer Panel - Disclosures as of 3/30/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Andrew J. Armstrong, MD, ScM

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Dendreon Corporation;
Johnson & Johnson;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

5/15/2013

Robert R. Bahnson, MD

Aveo,Inc.

Young,Ricchiuti,Caldwell, and Heller,LLC

None

None

11/12/2012

Anthony Victor D'Amico, MD, PhD

None

None

None

None

10/8/2012

James A. Eastham, MD

None

None

None

None

10/8/2012

Charles A. Enke, MD

None

None

None

None

11/1/2011

Thomas A. Farrington

None

None

None

None

8/6/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Celestia S. Higano, MD, FACP

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Dendreon Corporation;
Genentech, Inc.;
Algeta;
Teva

None

Medivation

12/31/2012

Maria Ho, PhD

None

None

None

None

8/3/2012

Eric Mark Horwitz, MD

None

None

None

None

5/22/2012

Philip W. Kantoff, MD

None

Amgen Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
BIND Biosciences, Inc.;
Cougar Biotechnology, Inc.;
Forest Pharmaceuticals, Inc.;
Gerson Lehrman Group, Inc;
Guidepoint Global;
Tokia

None

None

4/9/2012

Mark H. Kawachi, MD

None

None

None

None

5/8/2012

Michael Kuettel, MD, MBA, PhD

None

None

None

None

10/9/2012

Richard J. Lee, MD, PhD

None

Amgen Inc.

None

None

8/7/2012

Gary R. MacVicar, MD

None

Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

1/28/2013

Arnold W. Malcolm, MD, FACR

None

None

None

None

4/24/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

David Miller, MD, MPH

None

None

None

None

10/10/2012

James L. Mohler, MD

Roswell Park Cancer Institute

None

None

Androbiosys, Inc.

10/22/2012

Elizabeth R. Plimack, MD, MS

None

None

None

None

10/17/2012

Julio M. Pow-Sang, MD

None

Myriad Genetic Laboratories, Inc.

None

None

3/29/2013

Sylvia Richey, MD

None

sanofi-aventis U.S.

None

None

5/20/2013

Mack Roach III, MD

None

Ferring Pharma

None

None

10/18/2011

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Stan Rosenfeld

None

None

None

None

10/22/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Sandy Srinivas, MD

None

Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

11/5/2012

Cy Stein, MD, PhD

None

Amgen Inc.;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

3/16/2012

Seth A. Strope, MD, MPH

None

None

None

None

10/9/2012

Jonathan Tward, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

8/3/2012

Patrick C. Walsh, MD

None

None

None

None

7/31/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved